Genopathy
Gene-Disorder Association · Article
Gene
HTR2C
5-Hydroxytryptamine Receptor 2C
Manually curatedApproved treatment annotated
Association Review

In brief

The association between HTR2C (5-Hydroxytryptamine Receptor 2C) and Major Depressive Disorder is reported, with clinical genetic testing available.

Sources 1
Clinical variants 0
Symptoms 3
Compounds 18
Trials 402of 3,497 via HTR2C compounds
Publications 0
01
At a glance

Association overview

A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.

Request access
02
Provenance

Evidence and sources

1 source

Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.

Request access
03
HTR2C

The gene

2 source summaries

A gene summary alongside the source descriptions it was distilled from.

Request access
04
Major Depressive Disorder

The disorder

14 database identifiers

The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).

Request access
05
Phenotype

Clinical features

1 clinical feature

The disorder’s clinical features (HPO) grouped by body system, each with observed frequency and penetrance.

Request access
06
Interventions

Therapeutics

18 compounds & drugs

Gene-targeting drugs and associated compounds, with class, approval status, mechanism, indications and trials.

Request access
07
Human studies

Clinical trials

3,497 clinical trials

Clinical trials reached through the pair’s compounds, keeping disorder-targeting trials separate from other indications.

Request access
08
Provenance

References & sources

9 references

Every source and publication cited across this dossier, as one numbered reference list.

Request access